MS

Mamta Singh

Active Director Director DIN 06857709
DIN 06857709 First appointment May 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2014
Shareholding value •••• Premium profile

About Mamta Singh

Data last updated:

Mamta Singh is a Director at Prosaic Pharmaceuticals Private Limited (since 2014). The company operates in Pharma. Prosaic Pharmaceuticals Private Limited reported revenue of ₹1.38 Cr (FY 2025).

DIN 06857709
Primary Designation Director
Industry Pharma
First Appointment 15 May 2014
Oldest Company Age 12 yrs
Largest company Prosaic Pharmaceuticals Private Limited · ₹1.38 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 May 20142014₹1.38 Cr (FY 2025)Active

Board colleagues of Mamta Singh

NameDINCompanyDesignation
Sunil Kumar Singh06808892Prosaic Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Prosaic Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mamta Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mamta Singh

Mamta Singh currently holds 1 directorship: Prosaic Pharmaceuticals Private Limited (Director, since 15 May 2014, revenue ₹1.38 Cr (FY 2025)).

Mamta Singh was first appointed on 15 May 2014 as Director at Prosaic Pharmaceuticals Private Limited.

The current boards of Mamta Singh's companies include Sunil Kumar Singh (Prosaic Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available